NEW YORK, Aug. 3, 2015 /PRNewswire/ -- The fairness of the
proposed acquisition of Cytec Industries, Inc. ("CYT" or the
"Company") by Solvay S.A. ("Solvay") is the subject of an investigation by
WeissLaw LLP, a national class action, shareholder rights law firm.
The investigation focuses on possible breaches of fiduciary
duty and other violations of law by the Board of Directors of CYT
for agreeing to sell the Company to Solvay. On July 29,
2015, the Company announced it had reached a definitive agreement
for Solvay to acquire CYT in a
transaction valued at approximately $5.5
billion. Under the terms of the agreement, CYT
shareholders will receive $75.25 for
each CYT share they own.
WeissLaw is investigating whether CYT's Board acted in the best
interests of CYT's public shareholders by actively shopping the
Company to maximize shareholder value prior to entering into the
agreement with Solvay. If you own CYT shares and would like
more information about your rights or our investigation, or if you
have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771
or by email at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com or fill out the form
on our website,
http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a
similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/weisslaw-llp-cytec-industries-inc-acquisition-may-not-be-in-the-best-interest-of-cyt-shareholders-300122877.html
SOURCE WeissLaw LLP